Noticias

Noticias2019-05-13T18:54:06+02:00

FDA Allows Continued Sales of Textured Breast Implants

13/05/2019|Destacadas, Noticias|

The United States Food and Drug Administration (FDA) has announced that it will allow continued sales of textured breast implants, which regulators in other nations have banned or restricted because of concerns about a rare cancer, breast implant- associated anaplastic large cell lymphoma (BIA-ALCL).

Breast Implant ALCL: Excellent

25/03/2019|Portada|

The standard approach to treatment of breast implant–associated anaplastic large-cell lymphoma (BIA-ALCL) is complete oncologic resection, as per the 2019 National Comprehensive Cancer Network (NCCN) consensus guidelines.

‘Match point contra el cáncer de mama’

06/02/2019|Blog de la paciente, Noticias|

Las células madre tumorales, que son las iniciadoras y promotoras del cáncer, tienen especial capacidad para escapar a los tratamientos habituales (quimioterapia y radioterapia). Generalmente, el tumor se inicia en una zona específica del cuerpo y prolifera, migra e invade otras regiones a partir de la división de estas células.